Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and American Urological Association: endorsed by the American Society for Radiation Oncology (Q34505196)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and American Urological Association: endorsed by the American Society for Radiation Oncology
scientific article

    Statements

    Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and American Urological Association: endorsed by the American Society for Radiation Oncology (English)
    Glenn N Levine
    Anthony V D'Amico
    Peter Berger
    Peter E Clark
    Robert H Eckel
    Richard V Milani
    Arthur I Sagalowsky
    Matthew R Smith
    Neil Zakai
    American Heart Association Council on Clinical Cardiology and Council on Epidemiology and Prevention, the American Cancer Society, and the American Urological Association
    1 February 2010

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit